Position in EVO
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$12,261
New position
Shares Held
4,379
first reported quarter
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#23
of 34 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Global Retirement Partners, LLC holds $5,689,451 across 41 Drug Manufacturers - Specialty & Generic names. EVO ranks #21 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
10,222 | $1,722,815 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
1,509 | $817,621 | |
| 3 | TAK |
Takeda Pharmaceutical Co Ltd
|
38,613 | $618,966 | |
| 4 | VTRS |
Viatris Inc
|
23,981 | $380,818 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
15,299 | $376,508 | |
| 6 | AMRX |
Amneal Pharmaceuticals, Inc.
|
18,109 | $313,466 | |
| 7 | EOLS |
Evolus, Inc.
|
36,100 | $250,534 | |
| 8 | HLN |
Haleon plc
|
25,690 | $239,687 |
All Filings in EVO
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,261 | 4,379 | Shares | Sole | 2026-08-06 | |
| No filing history on record for this holder in this stock. | ||||||